Collectively, targeting ubiquitination pathways (BIM stabilization, Cbl-mediated c-KIT degradation, and GPX4-driven ferroptosis) reveals promising therapeutic strategies against GIST. Here, CBL is linked to gastrointestinal stromal tumor.